A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC
- Resource Type
- Article
- Authors
- Lai, Gillianne G.Y.; Yeo, Jia Chi; Jain, Amit; Zhou, Siqin; Pang, Mengyuan; Alvarez, Jacob J.S.; Sim, Ngak Leng; Tan, Aaron C.; Suteja, Lisda; Lim, Tze Wei; Guo, Yu Amanda; Shen, Meixin; Saw, Stephanie P.L.; Rohatgi, Neha; Yeong, Joe P.S.; Takano, Angela; Lim, Kiat Hon; Gogna, Apoorva; Too, Chow Wei; Da Zhuang, Kun; Tan, Wan Ling; Kanesvaran, Ravindran; Ng, Quan Sing; Ang, Mei Kim; Rajasekaran, Tanujaa; Wang, Lanying; Toh, Chee Keong; Lim, Wan-Teck; Tam, Wai Leong; Tan, Sze Huey; Skanderup, Anders M.J.; Tan, Eng-Huat; Tan, Daniel S.W.
- Source
- In JTO Clinical and Research Reports December 2022 3(12)
- Subject
- Language
- ISSN
- 2666-3643